Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective.

[1]  J. Couzinier,et al.  Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats. , 1986, European journal of pharmacology.

[2]  J. Young,et al.  Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. , 1985, Prostaglandins.

[3]  M. M. Goldenberg,et al.  A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat. , 1984, Prostaglandins.

[4]  P. Ramwell,et al.  Glucocorticoid protection against PAF‐acether toxicity in mice , 1983, British journal of pharmacology.

[5]  F. Cunha,et al.  In vitro reduction of human blood kininogen by catecholamines. , 1982, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[6]  O'Flaherty Jt.  Lipid mediators of inflammation and allergy. , 1982 .

[7]  D. Duval,et al.  Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. , 1982, Biochimica et biophysica acta.

[8]  S. Ferreira,et al.  A new method for measuring variations of rat paw volume , 1979, The Journal of pharmacy and pharmacology.

[9]  B. Vargaftig.  Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat , 1978, The Journal of pharmacy and pharmacology.

[10]  S. A. Turkanis,et al.  Barbiturate‐induced transmitter release at a frog neuromuscular junction , 1973, British journal of pharmacology.

[11]  M. Silva,et al.  Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating , 1973, British journal of pharmacology.

[12]  P. Henson,et al.  LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS , 1972, The Journal of experimental medicine.

[13]  N. Voelkel,et al.  Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.